Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
This grant opportunity aims to fund the creation of clinical research platforms focused on developing and testing tailored HIV cure strategies. The objective is to conduct trials that combine different HIV cure methods, specifically designed to suit individual participants, to determine their effectiveness. The findings of these studies will guide the development of comprehensive HIV treatment…
Source
Award
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health
-
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
National Institutes of Health ▸ National Institute on Alcohol Abuse and Alcoholism
-
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
National Institutes of Health
-
RFA #20818 AIDS Institute Clinical Guidelines Prog
New York State Grants
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers